Home\|Journals\|Articles by Year\|Audio Abstracts

A systematic scoping review of implementation of telepharmacy during COVID-19
Syed Arman Rabbani, Shrestha Sharma, Asiya Mahtab, Faheem Hyder Pottoo, Sathvik B. Sridhar
J App Pharm Sci. 2023; 13(4): 30-44
» Abstract » Full-text PDF » doi: 10.7324/JAPS.2023.113646
Potential sources of chemopreventive agents from Indonesian plants against colorectal cancer: A review
Maria Immaculata Iwo, Muhammad Andhika Alfaridzi, Hubbi Nashurullah Muhammad
J App Pharm Sci. 2023; 13(4): 11-29
» Abstract » Full-text PDF » doi: 10.7324/JAPS.2023.94509
Application of in silico methods in clinical research and development of drugs and their formulation: A scoping review
Luciana Ferreira Mattos Colli, Lúcio Mendes Cabral, Guacira Correa Matos, Carlos Rangel Rodrigues, Valeria Pereira de Sousa
J App Pharm Sci. 2023; 13(4): 1-10
» Abstract » Full-text PDF » doi: 10.7324/JAPS.2023.87792

Pages: 12

Articles by Year
	2024 (163) 2023 (283) 2022 (244) 2021 (242) 2020 (220) 2019 (225) 2018 (278) 2017 (392) 2016 (368) 2015 (333) 2014 (176)

SUBMIT your ARTICLE to Journal of Applied Pharmaceutical Science
Journal of Applied Pharmaceutical Science
Publisher :	Open Science Publishers LLP
Title :	Journal of Applied Pharmaceutical Science
Abbreviation :	J App Pharm Sci
e-ISSN :	2231-3354
Language(s) :	English
Web Page :	japsonline.com/index.php
Frequency :	12 issues per year
Subject :
List Articles from Journal of Applied Pharmaceutical Science

Online Article Submission

• ejmanager.com

ejPort - eJManager.com Refer & Earn JournalList	About BiblioMed License Information Terms & Conditions Privacy Policy	Contact Us
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.